Stay updated on Niraparib Combo With TSR-042 in Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the Niraparib Combo With TSR-042 in Ovarian Cancer Clinical Trial page.

Latest updates to the Niraparib Combo With TSR-042 in Ovarian Cancer Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe footer revision identifier was updated from v3.5.2 to v3.5.3, indicating a change to the site/versioning of the page itself rather than to the clinical trial record.SummaryDifference0.0%

- Check20 days agoChange DetectedPage revision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check27 days agoNo Change Detected
- Check49 days agoChange DetectedRevision log updated: added Revision v3.5.0; removed Revision v3.4.3.SummaryDifference0.0%

- Check56 days agoChange DetectedRevision update applied: v3.4.3 replacing the previous v3.4.2.SummaryDifference0.0%

- Check85 days agoChange DetectedAdded Revision: v3.4.2; removed the funding-lapse notice and Revision: v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check92 days agoChange DetectedAdded a general funding-status notice at the top of the page. Updated the page to version 3.4.1 and removed the 3.4.0 reference.SummaryDifference0.2%

Stay in the know with updates to Niraparib Combo With TSR-042 in Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Niraparib Combo With TSR-042 in Ovarian Cancer Clinical Trial page.